Birznieks Gunther 4
4 · Vanda Pharmaceuticals Inc. · Filed Aug 29, 2022
Insider Transaction Report
Form 4
Birznieks Gunther
SVP, Business Development
Transactions
- Exercise/Conversion
Common Stock
2022-08-26$3.12/sh+1,250$3,900→ 190,057 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2022-08-26−1,250→ 0 totalExercise: $3.12Exp: 2022-12-06→ Common Stock (1,250 underlying)
Footnotes (1)
- [F1]The option vested in 48 equal monthly installments beginning on December 7, 2012.